Economic Evaluation of HBV Birth Dose Vaccination
2020
This article, published in Cost Effectiveness and Resource Allocation, examines the cost-effectiveness of a birth dose of HBV vaccine in a medical setting in Ethiopia. The authors construct a decision analytic model with a Markov process to estimate the costs and effects of a birth dose of HBV vaccine, compared with current practices in Ethiopia. Based on the cost-effectiveness findings, introducing a birth dose of HBV vaccine in Ethiopia would likely be highly cost-effective. Such evidence can help guide policymakers when considering the inclusion of HBV birth dose vaccine into Ethiopia’s essential health services package.
Economic Evaluation of HBV Birth Dose Vaccination
Source:
Memirie ST, Desalegn H, Naizgi M et al. Introduction of Birth Dose of Hepatitis B Virus Vaccine to the Immunization Program in Ethiopia: An Economic Evaluation. Cost Effectiveness and Resource Allocation 2020; 18 (23). https://doi.org/10.1186/s12962-020-00219-7